TCS-OX2-29
Orexin antagonist
![]() | |
Identifiers | |
---|---|
| |
CAS Number |
|
PubChem CID |
|
IUPHAR/BPS |
|
CompTox Dashboard (EPA) |
|
Chemical and physical data | |
Formula | C23H31N3O3 |
Molar mass | 397.519 g·mol−1 |
3D model (JSmol) |
|
| |
(verify) |
TCS-OX2-29 is an orexin antagonist. It was the first non-peptide antagonist developed that is selective for the orexin receptor subtype OX2, with an IC50 of 40nM and selectivity of around 250x for OX2 over OX1 receptors.[1] Orexin antagonists are expected to be useful for the treatment of insomnia, with subtype-selective antagonists such as TCS-OX2-29 potentially offering more specificity of action compared to non-selective orexin antagonists like almorexant.[2]
References
- ^ Hirose M, Egashira S, Goto Y, Hashihayata T, Ohtake N, Iwaasa H, et al. (December 2003). "N-acyl 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline: the first orexin-2 receptor selective non-peptidic antagonist". Bioorganic & Medicinal Chemistry Letters. 13 (24): 4497–9. doi:10.1016/j.bmcl.2003.08.038. PMID 14643355.
- ^ Roecker AJ, Coleman PJ (2008). "Orexin receptor antagonists: medicinal chemistry and therapeutic potential". Current Topics in Medicinal Chemistry. 8 (11): 977–87. doi:10.2174/156802608784936746. PMID 18673167.
- v
- t
- e
Orexin receptor modulators
- Agonists: Orexin (A, B)
- Antagonists: ACT-335827
- ACT-462206
- ACT-539313
- Almorexant
- AZD-4041
- C4X-3256 (INDV-2000)
- CR-5542
- Daridorexant
- Filorexant
- GSK-649868 (SB-649868)
- JNJ-61393215
- Lemborexant
- RTIOX-276
- SB-334867
- SB-408124
- Suvorexant
- TCS-1102
- Vornorexant (ORN-0829, TS-142)
- YZJ-1139
- Agonists: Danavorexton (TAK-925)
- Firazorexton
- Orexin (A, B)
- SB-668875
- Suntinorexton
- TAK-861
- TAK-994
- Antagonists: ACT-335827
- ACT-462206
- Almorexant
- Daridorexant
- EMPA
- Filorexant
- GSK-649868 (SB-649868)
- JNJ-10397049
- Lemborexant
- MK-1064
- MK-3697
- MK-8133
- Seltorexant
- Suvorexant
- TCS-1102
- TCS-OX2-29
- Vornorexant (ORN-0829, TS-142)
- YZJ-1139
![]() | This sedative-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e